Table 2.

Future health research questions (consensus).

• Will rehabilitation in the AHSCT pathway result in further neurological improvement and long-term outcome? • Should a rehabilitation specialist be routinely part of the MDT to coordinate the rehabilitation and ensure outcome measures are obtained throughout the AHSCT pathway? • What are the best outcome measures to use in patients with MS undergoing AHSCT? Can specific outcome measures be developed for use with MS patients receiving AHSCT? • When is the optimal time to start rehabilitation in patients undergoing AHSCT? Does pre-habilitation have a role in AHSCT for patients with MS? • Should rehabilitation be provided to patients whilst in isolation, when they are most heavily immunosuppressed? If so, to what intensity? • Can length of hospital stay post-transplant be reduced? • Following discharge, should patients be referred into an intense sub-acute rehabilitation pathway either as an outpatient or into a step-down residential rehabilitation setting?